HXL Share Price Performance
AU$0
0.00 (0.00%)
Price AU$0
Share Pricen/a
No recently updated narratives available.
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company’s assets. Previously, the company was involved in the research and development of pezadeftide for the treatment of onychomycosis. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.